4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-063948
Director acquired 100,699 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ebeling Thomas Director | 2024-05-23 | Grant or award | +84,224 | $4.30 | $362,163 | 151,728 | D: show line 1 in the form |
| Ebeling Thomas Director | 2024-05-23 | Grant or award | +16,475 | $12.73 | $209,727 | 168,203 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ebeling Thomas Director | 2024-05-23 | Option exercise · Stock Option (Right to Buy) | −84,224 | 0 | D: show line 3 in the form | ||
| Ebeling Thomas Director | 2024-05-23 | Option exercise · Stock Option (Right to Buy) | −16,475 | 0 | D: show line 4 in the form |
Loading xslF345X05/ownership.xml…